Web23 uur geleden · See the latest Jounce Therapeutics Inc stock price (NASDAQ:JNCE), related news, valuation, dividends and more to help you make your investing decisions. Web15 mrt. 2024 · Shares Sold Short 3.18 M Change from Last -23.81% Percent of Float 7.24% Stock Money Flow N/A PROFILE ( JNCE) Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which...
Free Stock Tools – Financhill
Web10 apr. 2024 · Jounce Therapeutics stock bounces after saying only 1.4% of its cash was in an SVB operating account. Shares of Jounce Therapeutics Inc. JNCE, -6.09% bounced … Web4 apr. 2024 · 79,9%. More Financials. Company. Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. The Company is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients through a biomarker-driven approach. old toro push mower
JNCE Price Target 2024 Jounce Therapeutics Analyst Ratings
Web13 apr. 2024 · Jounce Therapeutics Inc. (NASDAQ:JNCE) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 1.07% to the previous day’s close as strong demand from buyers drove the stock to $1.89. Actively observing the price movement in the last trading, the stock closed the session at $1.87, Web14 apr. 2024 · Shares of NASDAQ:JNCE opened at $1.92 on Friday. Jounce Therapeutics has a 1 year low of $0.58 and a 1 year high of $7.23. The firm has a market capitalization of $100.11 million, a PE ratio of -0.75 and a beta of 0.75. The business's 50 day moving average price is $1.39 and its 200-day moving average price is $1.39. WebRidiculous price targets from analysts are much higher. POTUS SOTU re curing cancer may be a trigger for this - or not. First target 1.80. Stop double close below .95. Given the … old torrent programs